
Opinion|Videos|January 28, 2025
Standard of Care: Staging Considerations and Establishing Patient-Provider Relationships
Experts discuss the variability of non-muscle invasive bladder cancer (NMIBC) in terms of staging and risk stratification and how they navigate these diagnoses with their patients.
Advertisement
Episodes in this series

Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Arvin George, MD, highlights VAPOR 2 trial of thermal water therapy for prostate cancer
2
Trial launches of PSMA-targeting radioligand therapy in mCRPC
3
Eugene Pietzak, MD, discusses trial of chemoimmunotherapy strategy in NMIBC
4
Phase 2 data support TARA-002 activity in BCG-naïve NMIBC
5

















